arrow
S

Silvia Nardelli

Sapienza University of Rome
H指数:33
被引数:3,777

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Artificial Intelligence for Personalized Prediction of Post-TIPS Outcomes: Integrating Clinical, Biochemical, and Radiomics Data—A Narrative Review

人工智能用于经颈静脉肝内门体分流术后结局的个性化预测:整合临床、生物化学和放射组学数据——一篇叙述性综述

2026-08-120
OA
Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites

术前血清白蛋白浓度预测肝硬化伴腹水患者长期输注白蛋白的临床获益

2026-07-300
OAAI
Prevention of Portal Hypertension Complications Beyond Primary TIPS Indication Is Independent of Endoprosthesis Under-Dilation

门静脉高压并发症的预防超出初次TIPS适应证,与支架欠扩张无关。

2026-03-260
PRE
Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPS

分流量是门体分流术后显性肝性脑病的关键决定因素。

2025-11-110
OAAI
Real-world use of terlipressin in cirrhosis and acute kidney injury: frequent use beyond hepatorenal syndrome

特利加压素在肝硬化及急性肾损伤中的实际应用:超越肝肾综合征的频繁使用

2025-09-080
OAAI
Role of Gut-Derived Endotoxins in Porto-Sinusoidal Vascular Disorder: Comparison Between patients with and without portal hypertension

肠道源性内毒素在窦前血管疾病中的作用:有和无门静脉高压患者之间的比较

2025-08-080
OAAI
Letter on ‘Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicentre Real-World’

关于“TIPS术后显性肝性脑病增加肝硬化伴静脉曲张出血患者长期但非短期死亡率:一项大规模、多中心真实世界研究”的来信

2025-08-070
PREAI
Real-world experience with long-term albumin in patients with cirrhosis and ascites

在肝硬化伴腹水患者中应用长期白蛋白的临床经验

2024-12-010
OAAI